Todd Kinsella
47Patents
5h-index
42Co-inventors
69Inventor score
Filing activity: Apr 28, 1995 → Oct 7, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5830725A | Rapid, stable high-titre production of recombing retrovirus | Chemistry; Metallurgy | 37 | Expired |
| US7566685B2 | Methods and compositions for screening using diphtheria toxin constructs | Chemistry; Metallurgy | 13 | Active |
| US9145433B2 | GDF-8 inhibitors | Chemistry; Metallurgy | 12 | Active |
| US7105341B2 | In vivo production of cyclic peptides | Chemistry; Metallurgy | 11 | Expired |
| US7252952B2 | In vivo production of cyclic peptides for inhibiting protein—protein interaction | Physics | 8 | Expired |
| US10822337B2 | TGF-β inhibitorC | Chemistry; Metallurgy | 4 | Active |
| US7378248B2 | In vivo production of cyclic peptides for inhibiting protein-protein interaction | Chemistry; Metallurgy | 4 | Expired |
| US7208571B2 | In vivo production of cyclic peptides | Chemistry; Metallurgy | 4 | Expired |
| US9040462B2 | In vivo production of cyclic peptides for inhibiting protein-protein interaction | Chemistry; Metallurgy | 4 | Active |
| US9878992B2 | GDF-8 inhibitors | Chemistry; Metallurgy | 4 | Active |
| US7566765B2 | Heterocyclic compounds containing a nine-membered carbon-nitrogen ring | Chemistry; Metallurgy | 3 | Expired |
| US6979549B2 | Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein | Emerging Cross-Sectional Technologies | 3 | Expired |
| US9884868B2 | TGF-beta inhibitors | Human Necessities | 2 | Active |
| US7425418B2 | Compounds that modulate processes associated with IgE production | Physics | 2 | Expired |
| US7378251B2 | Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein | Human Necessities | 1 | Expired |
| US10781239B2 | In vivo engineered cereblon protein | Human Necessities | 1 | Active |
| US7604951B2 | Method for identifying compounds that modulate RXR associated processes with IgE production | Physics | 1 | Active |
| US7056687B2 | Methods and compositions for screening for altered cellular phenotypes | Physics | 1 | Expired |
| US7598050B2 | Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein | Physics | 1 | Active |
| US8796254B2 | Methods for using carboxamide, sulfonamide and amine compounds | Human Necessities | 1 | Active |
| US7060433B1 | Methods and compositions for screening using diphtheria toxin constructs | Chemistry; Metallurgy | 1 | Expired |
| US12227508B2 | TGF-β inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9511058B2 | Methods for using carboxamide, sulfonamide and amine compounds | Human Necessities | 0 | Active |
| US7141434B2 | Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase | Human Necessities | 0 | Expired |
| US10287295B2 | TGF-β inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.